Comparative Pharmacology
Head-to-head clinical analysis: AMOXICILLIN versus OMNIPEN N.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMOXICILLIN versus OMNIPEN N.
AMOXICILLIN vs OMNIPEN-N
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
Omnipen-N (ampicillin sodium) is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby interfering with transpeptidation and resulting in cell lysis.
250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 1 g orally every 8 hours.
250-500 mg orally every 6 hours for adults; for severe infections, up to 1 g every 6 hours.
None Documented
None Documented
Clinical Note
moderateAmoxicillin + Acemetacin
"Amoxicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."
Clinical Note
moderateAmoxicillin + Probenecid
"The serum concentration of Probenecid can be increased when it is combined with Amoxicillin."
Clinical Note
moderateAmoxicillin + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Amoxicillin."
Clinical Note
moderateAmoxicillin + Clotrimazole
Terminal elimination half-life: 1-1.5 hours in normal renal function. Prolonged to 7-20 hours in end-stage renal disease.
30-60 minutes (normal renal function); prolonged to 7-10 hours in severe renal impairment (CrCl <10 mL/min).
Renal: 60-80% unchanged via glomerular filtration and tubular secretion. Biliary: up to 20% excreted in bile. Fecal: minimal.
Primarily renal (80-90% unchanged via tubular secretion); minor biliary/fecal (<10%).
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic
"The metabolism of Clotrimazole can be decreased when combined with Amoxicillin."